DNA damage accumulates with age 1 . However, whether and how robust DNA repair machinery promotes longevity is elusive. Here, we demonstrate that activation of ataxiatelangiectasia mutated (ATM) via low dose of chloroquine (CQ) promotes DNA damage clearance, rescues age-related metabolic shift, and extends lifespan in nematodes and mice. Molecularly, ATM phosphorylates SIRT6 deacetylase and thus prevents MDM2-mediated ubiquitination and proteasomal degradation. Extra copies of Sirt6 in Atm-/-mice extend lifespan, accompanied with restored metabolic homeostasis. In a progeria mouse model with low ATM protein level and DNA repair capacity, the treatment with CQ ameliorates premature aging features and extends lifespan. Thus, our data highlights a pro-longevity role of ATM, for the first time establishing direct causal links between robust DNA repair machinery and longevity, and providing therapeutic strategy for progeria and age-related metabolic diseases.
Introduction
A variety of metabolic insults frequently generate DNA lesions in mammalian cells, which, if wrongly repaired, may lead to somatic mutations and cell transformation 2 ; if unrepaired, may accumulate and constantly activate DNA damage response (DDR), a unique feature and mechanism of senescence 3, 4 . Ataxia telangiectasia mutated (ATM), a serine/threonine protein kinase, belongs to these key regulators of DDR 5 . Upon DNA damage, self-activated ATM phosphorylates downstream transducers and effectors, thus promoting DNA repair 6, 7 . H2AX is one well-documented phosphorylation target of ATM; phosphorylated H2AX at S139 (γH2AX) is widely applied as a hallmark of DNA damage 8 . Accompanied with DNA repair function decline, γ H2AX-enriched DNA damage foci accumulate in senescent cells and in tissues from aged animals 9 , supporting causal links between defective DDR and aging. In addition to γ H2AX, CHK2, p53, SMC1, NBS1, BRCA1 and MDC1 are all ATM substrates 10 , of which phosphorylated
Chk2 and p53 are key players of DDR-induced cell cycle arrest. In human fibroblasts, a dramatic decline of homologous recombination (HR) efficiency, attributable to defective recruitment of Rad51, was observed 11 . Similar defects in HR were also observed in
Hutchinson-Gilford progeria syndrome (HGPS), which is predominantly caused by a LMNA G608G mutation 12 . In addition to DNA damage accumulation, inherited loss-offunction mutations in essential components of DNA repair machinery also accelerate aging in humans and mice 13 . Patients suffering from ataxia telangiectasia (A-T) develop prominent aging features in their second decades 14, 15 . Werner syndrome, Bloom's syndrome and Rothmund-Thomson syndrome are all progeria syndromes caused by mutations of genes that directly regulate DNA repair [16] [17] [18] [19] . Homozygous disruption of Atm in mice recapitulates many premature aging features of A-T, like growth retardation, infertility, neurodegeneration, immunodeficiency and cancer predisposition 20 . Mouse models deficient in DNA repair elements, including DNA-PKcs, Ku70, Ku80, DNA ligase IV, Artemis or Ercc1, phenocopy premature aging features 21, 22 . However, though tons of evidences support that defects in DNA repair accelerate ageing, whether and how robust DNA repair machinery promotes longevity is poorly understood.
Metabolic disturbance is another antagonistic hallmark of aging 23 . Although DNA repair deficiency is implicated in aging and age-related diseases including metabolic disorders 24, 25 , the mechanistic linker between DNA repair machinery and metabolic reprogramming in aging is poorly understood. Notably, in response to oxidative stress, ATM phosphorylates Hsp27 thus to shift glucose metabolism from glycolysis to the pentose phosphate pathway (PPP) 26, 27 . Inactivating ATM enhances glucose and glutamine consumption by inhibiting P53 and upregulating c-MYC 28 . The role of ATM in age-onset metabolic disturbances is yet unclear. On the other front, longevity-promoting genes, like NAD + -dependent sirtuins, are able to shunt energy metabolism away from anaerobic glycolysis toward TCA cycle 29, 30 . Sirt6 cooperates with Hypoxia inducible factor-1α (HIF1α) via deacetylating transcription-active epigenetic marks to regulate glucose homeostasis 31 , and also modulates aerobic glycolysis 32 . Loss of Sirt6 accelerates aging, accompanied with hypoglycemia and genomic instability 33, 34 , whereas ectopic Sirt6 inhibits insulin and insulin-like growth factor 1 (IGF1) signaling and extends lifespan in male mice 35 . Owing to up-regulated metabolic genes like glucose transporter GLUT-1, lactate dehydrogenase (LDH) and pyruvate dehydrogenase kinase (PDK), the glycolytic activity and lactate production were dramatically increased in Sirt6-/-cells and tumors 32 .
Here, we identified a progressive decline in ATM-centered DNA repair machinery during aging, along with shunted glucose metabolism to glycolysis. DNA damage-free activation of ATM by chloroquine (CQ) promotes DNA damage clearance, rescues the age-related metabolic shift, and extends lifespan in both nematodes and mice. Mechanistically, ATM phosphorylates and stabilizes pro-longevity protein SIRT6. Extra copies of Sirt6 attenuate metabolic abnormality and extend lifespan in Atm-/-mice, and long-term treatment of CQ restores metabolic shift and extends lifespan in a progeria mouse model.
Results

ATM alleviates replicative senescence
In searching for genes/pathways that drive senescence, a gradual decline of ATMcentered DNA repair machinery was identified by RNAseq analysis ( Supplementary Fig.   1a -e). Western blotting analysis confirmed progressively downregulated protein levels of ATM and its downstream target NBS1 and RAP80 in senescent human skin fibroblasts (HSFs) (Fig. 1a) . Mouse embryonic fibroblasts (MEFs) with a limited growth capacity and senescent phenotypes when cultured in vitro [36] [37] [38] , and brain tissues from aged mice also showed progressive decline of ATM, NBS1, and PAP80 (Fig. 1b-c) . Concomitantly, a reciprocal upregulation of γ H2AX, indicating accumulated DNA damages, and p16
Ink4a level was observed in senescent HSFs, MEFs, and aged brain tissues (Fig. 1a-c) .
Knocking down ATM via shRNA accelerated senescence in HSFs, evidenced by increased β -galactosidase activity ( Fig. 1d-e) , enlarged morphology ( Supplementary   Fig.2a ), accumulated γ H2AX (Fig. 1f) and reduced cell proliferation ( Supplementary Fig.   2b ). Thus, ATM decline retards DDR and drives senescence.
Other than DNA damage, ATM can be activated by chloroquine (CQ), an antimalarial drug that modulates chromatin confirmation 6 . Indeed, we found that low dose of CQ increased pS1981 auto-phosphorylation of ATM but not γ H2AX ( Supplementary Fig. 2c ).
We then investigated whether activating ATM by CQ ameliorates senescence. As shown, the CQ treatment activated ATM (pS1981), promoted clearance of DNA damage (γH2AX), and inhibited apoptosis (cleaved Casp3) in HSFs (Fig. 1g) . Also, the CQ treatment suppressed β -galactosidase activity, but that was abrogated when ATM was knocked down (Fig. 1h-i) . Likewise, the CQ treatment activated Atm, cleared up accumulated DNA damage (Fig. 1j) , suppressed Of note, ATM KD or low dose of CQ applied in this study had little effect on basal autophagic activity (Fig. 1f, j and Supplementary Fig. 2g ). Collectively, CQ activates ATM to alleviate replicative senescence. 
An ATM-SIRT6 axis underlies age-associated metabolic reprogramming
A-T patients lacking functional ATM display features of premature aging, accompanied with insulin resistance and glucose intolerance 39, 40 . Senescent cells exhibit enhanced glycolysis but impaired mitochondrial respiration, and increased lactate for ATP generation 41, 42 . As such, we must ask whether ATM decline triggers age-associated metabolic shift. Indeed, glycolytic gene LDHB and PDK1 were dramatically increased in senescent MEFs and HSFs ( Fig. 2a and Supplementary Fig. 3a) , and in liver tissues from
Atm-/-mice ( Supplementary Fig. 3b ). Significantly, activating ATM via CQ suppressed senescence-associated glycolysis ( Fig. 2a and Supplementary Fig. 3a ). The inhibitory effect on glycolysis was diminished when ATM was depleted in HepG2 cells (Fig. 2b) , suggesting the role of ATM in inhibiting glycolysis.
To address how ATM regulates glycolysis, we performed RNA-Seq in Atm-/-MEF cells, and revealed a significant upregulation of glycolytic pathways (Fig. 2c) . Specific genes were validated by q-PCR ( Supplementary Fig. 3c ). As p53 is critical in glycolysis 43, 44 , we further analyzed metabolomics of Atm-/-and control MEF cells in p53 null background.
As shown, the metabolic profile exhibited a clear shift, i.e. mitochondrial electron transport chain and intermediates of TCA cycle were reduced, while intermediates of glycolysis were elevated (Fig. 2d, Supplementary Fig. 3d -e and Table S1 ). The data suggest ATM deficiency enhances anaerobic glycolysis in a p53-independent manner.
Sirt6 deacylase is able to shunt energy metabolism away from anaerobic glycolysis to TCA cycle via H3K9ac-mediated local chromatin remodeling 31, 32 . We noted the level of H3K9ac was enhanced in cells depleted ATM (Fig. 2e) . Re-expressed ATM in A-T cells suppressed H3K9ac level (Fig. 2f) . Further ChIP analysis showed that H3K9ac was enriched at the promoter regions of glycolytic genes in Atm-/-cells ( Fig. 2g) Fig. 3f-i ). In contrast, other sirtuins were merely affected (Fig. 2i) , and mRNA levels of all sirtuins remained unchanged ( Supplementary Fig. 3j ). Moreover, transcriptomic analysis and q-PCR data illustrated that Sirt6 depletion upregulated a similar cluster of genes essential for glycolysis ( Supplementary Fig. 4a-b and Table S2 ). More importantly, the hyperactivated glycolytic pathway caused by ATM deficiency was completely restored by ectopic SIRT6 in HepG2 cells ( Supplementary Fig. 4c ). The CQ treatment upregulated SIRT6 level and reduced H3K9ac level, especially at regulatory regions of glycolytic genes ( Supplementary Fig. 4d -e). Knocking down SIRT6 abolished the inhibitory effect of CQ on glycolysis (Fig. 2b) . Though levels of SIRT1 and SIRT7 were also declined along with senescence, they were not restored by CQ treatment (Supplementary Fig. 4f ).
Additionally, ATM depletion in HEK293 cells, HSFs and MEFs, significantly downregulated SIRT6 protein level, with no effect on SIRT1 or SIRT7 protein level ( Fig.   2i and Supplementary Fig. 4g-h ). Thus, these data suggest ATM decline triggers ageassociated metabolic shift via SIRT6-mediated chromatin remodeling.
Other than metabolic abnormality, depleting Sirt6 leads to various premature aging features and shortened lifespan 45 , whereas extra copies of Sirt6 promotes longevity in male mice 35 . Given that Sirt6 was destabilized in Atm null mice, we asked whether Sirt6 transgene could rescue premature aging phenotypes and shortened lifespan in Atm-/-mice.
To this end, we generated Sirt6 transgenic mice by microinjection, and bred them with
Atm-/-mice. The overexpression of Sirt6 was demonstrated by Western blotting (Supplementary Fig. 4i ). Significantly, ectopic Sirt6 restored the elevation of serum lactate and blood glucose levels, and extended lifespan of Atm-/-mice in both genders ( Fig. 2j and Supplementary Fig. 4j-k) . Importantly, Atm-/-; Sirt6-tg mice exhibited improved glucose tolerance and decreased insulin resistance ( Fig. 2k-l ). Given little difference was observed in glucose metabolism between young WT and Sirt6-transgenic mice 35 , these data suggest a contributing role of the Atm-Sirt6 axis in the age-associated metabolic reprogramming. 
ATM phosphorylates and stabilizes SIRT6
Next, we examined how ATM regulates SIRT6. Significantly, the overexpression of ATM increased SIRT6 level, but that was abolished when ATM was S1981A-mutated ( Fig. 3a) .
Of note, the S1981A mutation blocks dimeric ATM dissociation and therefore the ATM activation 6 . Moreover, in addition to CQ, hypotonic buffer (20 mM NaCl), low glucose (Fig. 3b) . The interaction was further confirmed at both ectopic and endogenous levels ( Fig. 3c and Supplementary Fig. 5d ). Immunofluorescence microscopy showed co-localization of SIRT6 and ATM protein in the nucleus (Fig. 3d ). Domain mapping experiment indicated that the C-terminal domain was required for SIRT6 binding to ATM ( Supplementary Fig. 5e ). To determine whether ATM physically binds to SIRT6, 10 consecutive recombinant GST-ATM proteins were obtained and the binding to purified His-SIRT6 was analyzed. As shown, His-SIRT6 strongly bond to GST-ATM-4 (residues 770-1102) (Fig. 3e) , the N-terminal HEAT repeat domain of ATM, which are predicted to bind to phosphorylation substrates, such as NBS1 46 .
We next examined whether ATM phosphorylates SIRT6. Firstly, we found the CQ or CPT treatment significantly enhanced the binding of SIRT6 to ATM ( Fig. 3f and Supplementary Fig. 5f ), whereas the S1981A mutant blocked such association ( Supplementary Fig. 5g ). ATM preferentially phosphorylates S/T-Q motif. In the presence of CPT, the increased p-S/TQ level of SIRT6 was identified ( Fig. 5j ). Indeed, SIRT6 has one evolutionarily conserved S 112 Q 113 motif (Fig. 3k) . We therefore constructed S112A and S112D mutations, which resembles hypo-and hyper-phosphorylated form respectively. As shown, these mutations almost abolished the pS/T-Q level of FLAG-SIRT6 (Fig. 3l) .
Further in vitro kinase assay showed that ATM could phosphorylate GST-SIRT6, but not S112A mutant ( Supplementary Fig. 5k ). Collectively, the data suggest that ATM directly phosphorylates SIRT6 at Serine 112. Flag-SIRT6, Flag-SIRT6 S112A, or Flag-SIRT6 S112D in HEK293 cells.
We next examined whether ATM is involved in regulating SIRT6 protein stability.
Notably, compared to wild-type or vehicle control, the degradation rates of ectopic and endogenous SIRT6 were largely increased in ATM KO HEK293 cells, Atm-/-MEFs, or cells incubated with ATM specific inhibitor KU55933 in the presence of cycloheximide (CHX) (Fig. 4a-b and Supplementary Fig. 6a-c) . Recently MDM2 was demonstrated to ubiquitinate SIRT6 and promote its proteasomal degradation 51 . We therefore examined the polyubiquitination level of SIRT6. As shown, the ubiquitination level of FLAG-SIRT6 in ATM KO cells was significantly elevated compared with wild-type ( Supplementary Fig. 6d ). While the S112A mutant markedly enhanced polyubiquitination level of SIRT6, the S112D merely affected it ( Supplementary Fig. 6e ).
Moreover, the S112A accelerated SIRT6 degradation, whereas the S112D retarded it ( Fig. 6f ). In case of ATM depleted or SIRT6 S112A-mutated, the binding capacity of SIRT6 to MDM2 was enhanced ( Fig. 4e and Supplementary Fig. 6g ). In searching for key residues that are poly-ubiquitinated by MDM2, we identified two clusters of lysine residues, i.e. K143/145 and K346/349, which are conserved across species. We then generated KR mutations of these residues, and found K346/349R remarkably reduced the poly-ubiquitination level of SIRT6 ( Supplementary Fig. 6h ). Individual KR point mutation showed that K346R significantly blocked MDM2-mediated ubiquitination and degradation of SIRT6, whereas K349R hardly affected it (Fig. 4f-g ). More importantly, the K346R restored the increased ubiquitination and accelerated protein degradation of SIRT6 S112A ( Supplementary Fig.   6i -j). Collectively, these data indicate that K346 is subjected to MDM2-mediated ubiquitination and is responsible for the degradation of SIRT6, which is inhibited by ATM-mediated S112 phosphorylation. ***P < 0.001.
Activating ATM via CQ promotes longevity
The cellular data suggest a pro-longevity function of ATM. We then tested it at organismal level. We employed Caenorhabditis elegans, which have a short lifespan of approximate 30 days. Nematodes deficient for atm-1, an orthologue of mammalian ATM, and wild-types were exposed to various doses of CQ (see Materials and Methods).
Significantly, the period treatment with CQ (1.0 µM) extended the median lifespan (~14%) of C. elegans (Fig. 5a ). The lifespan-extending effect was abolished in atm-1 KO (Fig. 5b ) or in SIRT6 homolog sir-2.4 KD nematodes ( Supplementary Fig. 7a-b) . The data suggest that CQ promotes longevity in an ATM-and SIRT6-dependent manner. We further examined the beneficial effect of CQ in a HGPS model, i.e. Zmpste24-/-mice, which has a shortened lifespan of 4-6 months 52 and impaired ATM-mediated DNA repair signaling 53 . Here we found, Atm level was dramatically reduced in Zmpste24-/-cells and tissues ( Supplementary Fig. 7c-d) . Significantly, the CQ treatment activated Atm, stabilized Sirt6, decreased the accumulated DNA damage, inhibited glycolysis, and alleviated senescence in Zmpste24-/-cells (Fig. 5c-d and Supplementary Fig. 7e-f) . The CQ treatment also held off body weight decline, increased running endurance, and prolonged lifespan in Zmpste24-/-mice ( Fig. 5e-f and Supplementary Fig. 7g ). We then extended the study to physiologically aged mice. In this case, 12-month-old "old" male mice were intraperitoneally administrated with lose dose of CQ (3.5mg/kg) twice a week.
Remarkably, compared to the saline-treated control group, the CQ treatment inhibited glycolysis, lowered down serum lactate level, attenuated body weight decline (Fig. 5g-h and Supplementary Fig. 7h ). Most remarkably, the CQ treatment enhanced survival rate of physiologically aged mice (p < 0.05), but showed no significant effect in Atm-/-mice (Fig. 5i) . Generally, these data demonstrate a lifespan-extending benefit of ATM activation by CQ. Kaplan-Meier survival curves of saline-treated and CQ-treated aging C57BL/6J mice (n = 12 for each group) and Atm-/-mice (n = 9 for each group). *P < 0.05.
Discussion
DNA damage accumulates with age and defective DNA repair accelerates aging.
However, whether boosting DNA repair machinery promotes healthiness and longevity is still obscure. DNA damage stimulates DDR, but if persisted, it rather leads to senescence.
Therefore, if enhancing DDR efficacy possibly promotes longevity, it must be DNA damage free. The antimalarial drug CQ could intercalate into the internucleosomal regions of chromatin, unwind DNA helical twist, and thus activate ATM without causing any DNA damage 6, 54 . We demonstrate that long-term treatment with CQ activated ATM, slowed down senescence, restored age-related metabolic shift, and extended lifespan in both nematodes and mice. Mechanistically, ATM phosphorylated longevity gene SIRT6 55 , and prevented the MDM2-mediated ubiquitination and proteasomal degradation of SIRT6. To our knowledge, it is the first time establishing direct causal links between robust DNA repair machinery and longevity. Supporting this notion, the DNA repair efficacy is found enhanced in long-lived naked mole rat 56 CQ is FDA-approved and clinically used medicine for treatment of malaria 75 . Through the activation of ATM, long-term treatment of CQ protects against atherosclerosis, improves insulin sensitivity, and rescues glucose tolerance in type 2 diabetes (T2D) models [76] [77] [78] . Lysosomotropic property of CQ also make it as a potent inhibitor of autophagy 79 . The dose (7.0 mg/kg/week in mice) applied in this study is equivalent to 35 mg/week for humans, much lower than that suggested for antimalarial treatment (500 mg/week, maximum 0.8 µM in plasma) and that for cancer therapy via autophagic inhibition (100-500 mg/day) 80 . Indeed, no obvious autophagic inhibition was observed in our study. The administration of CQ was conducted by intraperitoneal injection as described 78 . It seems that the frequently induced stress by repeated intraperitoneal injection imposes negative effect on lifespan, as saline-treated animals died earlier than untreated. Nonetheless, we treated the two groups of animals under the same conditions (age, diet, health status), and found that CQ-treated C57BL/6J mice exhibited much longer lifespan than saline-treated. When we summarized the lifespan data, i.e. ~840 days after birth of tested animals, which is equivalent to the median lifespan of C57BL/6J 35, 67, 81 , more than 60% CQ-treated mice are still alive. Therefore, we believe that the effect of CQ is not just an adaption to chronic stress induced by intraperitoneal injection but rather reflects a general regulation of murine lifespan.
In conclusion, our data establish direct causal links between robust DNA repair machinery and longevity. Together with DNA damage theory of aging, we propose that DNA damage activates DDR, however its constant activation causes senescence;
defective ATM-SIRT6 axis underlies premature ageing, exemplified by HGPS and A-T mouse models, which are rescued by treatment of CQ and Sirt6 transgene respectively; in physiological ageing, DNA damage-free activation of ATM by CQ stabilizes SIRT6, thus promoting longevity in both nematodes and mice ( Supplementary Fig 8) . Our findings also provide a novel therapeutic strategy for HGPS, and could facilitate clinical trials of CQ as an effective treatment for aging-related diseases.
Experimental Procedures Mice
Zmpste24-/-mice and Atm-/-mice have been described previously 20, 52 . 
C. elegans survival assay
C. elegans nematode survival assay was performed according to standard protocols 82 .
Briefly, wild-type and atm-1 null nematodes (100 to 150 per group) synchronized to prefertile young adult stage were exposed to NGM plates containing the indicated dosage of CQ. After 1-day incubation, animals were transferred to fresh incubation plates without CQ for another 2 days. This procedure was repeated every three days. Nematodes that showed no response to gentle stimulation were recorded as dead. The survival data was analyzed by Kaplan-Meier method and statistical comparison was performed by Log-rank Test.
Cell lines
HEK293, immortalized mouse embryonic fibroblasts (MEFs), human skin fibroblasts (HSFs), HepG2 and U2OS cells were cultured in Gibco ® DMEM (Life Technologies, USA) with 10% fetal bovine serum (FBS), 100 U/ml penicillin and streptomycin (P/S) at 37 ℃ in a 5% CO 2 humidified atmosphere. Primary MEFs were generated from 13.5-day-old embryos as described 12 , and were cultured in DMEM supplemented with 0.1 mM nonessential amino acids (Life Technologies), 0.1 mM 2-mercaptoethanol (SigmaAldrich, USA). For CQ experiments, cells were maintained in the medium containing 1μM chloroquine for 12 h, and then grown in new fresh medium for 48 h. 
Cell lines Description and Application in this study
Plasmids
Human Flag-SIRT6, pcDNA3.1 Flag-ATM, Flag-ATM S1981A, and pcDNA3 human MDM2 were all purchased from Addgene (Cambridge, MA). Flag-SIRT6 with amino acid substitution mutations (S112A, S112D, K346R/K349R) were generated by PCRbased mutagenesis using pcDNA3-Flag-SIRT6 as a template and QuikChange II sitedirected mutagenesis kit (Agilent Technologies), following the manufacturer's instruction.
Primer sequences for amino acid mutations of SIRT6 were as follows: SIRT6 S112A: 
Protein extraction and Western blotting
For whole cell protein extraction, cells were suspended in 5 volumes of suspension buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, protease inhibitor cocktail), and then added 5 volumes of 2X SDS loading buffer and incubated at 98 °C for 6 min. Mice tissues were homogenized with 1mL of ice-cold tissue lysis buffer (25 mM TrisHCl, pH 7.5, 10 mM Na 3 VO 4 , 100 mM NaF, 50 mM Na 4 P 2 O 7 , 5 mM EGTA, 5 mM EDTA, 0.5% SDS, 1% NP-40, protease inhibitor cocktail). After homogenization and sonication, lysates were centrifuged at 16,000 g for 15 min. The clean supernatant was carefully transferred to new tubes. Protein concentrations were determined by using bicinchoninic acid (BCA) assay method (Pierce, Rockford, IL) and were normalized with lysis buffer for each sample. Samples were denatured in 1X SDS loading buffer by boiling at 98 °C for 6 min. Proteins were separated by loading to SDS-polyacrylamide gels, and then were transferred to PVDF membrane (Millipore). The protein levels were determined by immunoblotting using respective antibodies. The ImageJ program was used for densitometric analysis of immunoblotting, and the quantification results were normalized to the loading control.
Antibodies
Rabbit anti-SIRT6 (ab62739), ATM (ab78), SIRT1 (ab12193), 
CRISPR/Cas9-mediated genome editing
Gene mutagenesis by CRISPR/Cas9 system was conducted as described 85 
EdU (5-ethynyl-2'-deoxyuridine) incorporation assay
EdU incorporation assays were conducted in HSF cells to estimate cell proliferation using the Click-iT™ EdU Alexa Fluor ® 488 Kit (Invitrogen). HSF cells, infected by the respective lentiviruses containing shNC and shATM, were cultured in a 6-well plates containing the coverslips in the presence of 10μM EdU for 12 hours. Cells were fixed in 3.7 % formaldehyde followed by a 0.5% Triton X-100 permeabilization, and then stained with Alexa Fluor picolyl azide. Five random views were captured to calculate the positive staining rate for each group.
Growth curves and SA-β-gal assays
Cell population doublings were monitored using a Coulter Counter. SA-β-galactosidase assay in primary cells was performed using Senescence beta-galactosidase staining Kit (#9860, CST) according to manufacturer instructions, five views were captured randomly to calculate the positive staining rate for each group.
RNA Preparation and Real-Time qPCR
Total RNA was extracted from cells or the tissues of mice using Trizol ® reagent RNAiso Plus (TaKaRa, Japan) following the phenol-chloroform extraction method. Purified total RNA was used to obtain cDNA using PrimeScript TM RT Master Mix (Takara, Japan) following this method: 37 
Glucose tolerance test
Mice were fasted overnight (6 p.m. to 9 a.m.), and D-glucose (2.5 g/kg body weight) was administrated intraperitoneally. Blood glucose levels were determined from tail vein blood using glucometer (Onetouch ® ultravue, Johnson) at 0, 30, 60, 90, and 120 min after D-glucose injection.
Insulin tolerance test
Mice were fasted for 6 hours (8 a.m. to 2 p.m.), and recombinant human insulin (0.75 U/kg body weight) was administered intraperitoneally. Blood glucose levels were determined from tail vein blood using glucometer (Onetouch ® ultravue, Johnson) at 0, 30, 60, 90, and 120 min after insulin injection.
Lactate assay
Mouse serum was five-fold diluted, and lactate concentration was determined with the Lactate Colorimetric Assay Kit (BioVision).
Endurance running test
Zmpste24-/-mice were treated for 8 weeks with chloroquine or saline before running on a Rota-Rod Treadmill (YLS-4C, Jinan Yiyan Scientific Research Company, Shandong, China) to test the effect of chloroquine on fatigue resistance. Mice were placed on the rotating lane, and the speed was gradually increased to 10 r/min. When mice were exhausted and safely dropped from the rotating lane, the time latency to fall were automatically recorded.
Metabolite analysis
Wild-type and ATM KO cells were grown in normal medium for 24 hours, and methanolfixed cell pellets were analyzed by two liquid chromatography-tandem mass spectrometry (LC-MS) method as described 86 .
Immunofluorescence microscopy
The cells were fixed using 4% paraformaldehyde at room temperature for 15 min, and then permeabilized using 0.5% Triton X-100 at room temperature for 10 min, blocked using 10% FBS/PBS, and stained using primary antibodies diluted in PBS containing 2%
BSA overnight at 4 . The primary antibodies were detected using an Alexa-488-conjugated anti-mouse secondary antibody (Invitrogen). The nuclei were stained using DAPI in anti-fade mounting medium. Images were captured using Zeiss LSM880 confocal/multiphoton microscope.
ChIP assay
Cells were fixed in 1% formaldehyde for 10 min at room temperature. 
